Dolby Laboratories (DLB) Projected to Post Quarterly Earnings on Wednesday

Dolby Laboratories (NYSE:DLBGet Free Report) will likely be announcing its earnings results after the market closes on Wednesday, January 29th. Analysts expect the company to announce earnings of $1.07 per share and revenue of $346,145.33 billion for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Dolby Laboratories Price Performance

Shares of Dolby Laboratories stock opened at $79.67 on Monday. The stock has a market capitalization of $7.60 billion, a price-to-earnings ratio of 29.40 and a beta of 0.98. The business has a 50-day moving average of $78.79 and a 200 day moving average of $75.60. Dolby Laboratories has a 12 month low of $66.35 and a 12 month high of $85.84.

Dolby Laboratories Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 10th. Stockholders of record on Tuesday, December 3rd were paid a $0.33 dividend. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.30. The ex-dividend date was Tuesday, December 3rd. This represents a $1.32 annualized dividend and a dividend yield of 1.66%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 48.71%.

Insider Buying and Selling

In other news, EVP Mark Andrew Sherman sold 12,338 shares of the company’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $78.08, for a total value of $963,351.04. Following the completion of the transaction, the executive vice president now owns 62,397 shares in the company, valued at approximately $4,871,957.76. This represents a 16.51 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Peter C. Gotcher sold 6,079 shares of the stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $78.96, for a total transaction of $479,997.84. Following the completion of the transaction, the director now directly owns 37,593 shares in the company, valued at $2,968,343.28. This trade represents a 13.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 135,917 shares of company stock worth $10,877,739 over the last 90 days. 38.39% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on DLB shares. Rosenblatt Securities reiterated a “buy” rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Thursday. Barrington Research reiterated an “outperform” rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research note on Wednesday, November 20th. Finally, StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, December 4th.

Get Our Latest Stock Report on Dolby Laboratories

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Read More

Earnings History for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.